Document Detail


The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
MedLine Citation:
PMID:  12592337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In response to PMA treatment K562 myelogenous leukemia cells undergo megakaryocytic differentiation, which is dependent on prolonged ERK activation and is characterized by growth arrest, upregulation of CD41 and IL-6, and, finally, by characteristic changes in cell morphology. The tyrosine phosphatase HePTP was recently demonstrated to regulate ERK activity and changes in HePTP expression have been associated with hematopoietic malignancies. Here, we have studied the function of HePTP during PMA-induced megakaryocytic differentiation of K562 cells. Overexpression of HePTP or inhibition of HePTP expression with antisense cDNA had no effect on PMA-induced cell cycle arrest or upregulation of cyclin D in K562 cells. The expression of megakaryocytic markers such as CD41 and IL6, however, were highly reduced in cells overexpressing HePTP, due to reduced ERK activation, and the cells were impaired in their ability to differentiate. Compared to control cells, HePTP antisense expressing cells did not show increased basal or PMA-induced ERK activity. However, antisense inhibition of HePTP enhanced nuclear translocation of ERK and the expression of the megakaryocytic markers CD41 and IL-6. Interestingly, like cells overexpressing HePTP, morphological differentiation was also impaired in HePTP antisense expressing cells. The results for the first time demonstrate that different aspects of megakaryocytic differentiation have distinct requirements for ERK activity. They further show that HePTP is involved in the regulation of nuclear translocation of ERK2 and that HePTP protein levels can modulate K562 cell differentiation.
Authors:
S M Pettiford; R Herbst
Related Documents :
14643407 - Differentiation of fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by...
16901537 - Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell...
7032707 - Changes in acid proteolytic activity during differentiation of murine erythroleukemic c...
2420477 - Adipocyte differentiation of 3t3-l1 cells in serum-free hormone-supplemented media: eff...
23947917 - Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membr...
22951927 - Autophagy plays a protective role in endoplasmic reticulum stress-mediated pancreatic β...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Leukemia     Volume:  17     ISSN:  0887-6924     ISO Abbreviation:  Leukemia     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-19     Completed Date:  2003-04-11     Revised Date:  2013-03-04    
Medline Journal Info:
Nlm Unique ID:  8704895     Medline TA:  Leukemia     Country:  England    
Other Details:
Languages:  eng     Pagination:  366-78     Citation Subset:  IM    
Affiliation:
DNAX Research Institute, 901 California Avenue, Palo Alto, CA 94304, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Active Transport, Cell Nucleus
Antigens, CD / genetics
Cell Cycle / drug effects
Cell Differentiation / drug effects,  physiology*
DNA, Antisense / pharmacology*
Gene Expression Regulation, Neoplastic
Humans
Intracellular Signaling Peptides and Proteins
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Megakaryocytes / cytology*,  drug effects
Mitogen-Activated Protein Kinase 1 / metabolism*
Platelet Membrane Glycoprotein IIb / genetics
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Protein Tyrosine Phosphatases / genetics,  metabolism*
Protein Tyrosine Phosphatases, Non-Receptor
Tetradecanoylphorbol Acetate / pharmacology*
Transfection
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/DNA, Antisense; 0/Intracellular Signaling Peptides and Proteins; 0/Platelet Membrane Glycoprotein IIb; 16561-29-8/Tetradecanoylphorbol Acetate; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 3.1.3.48/PTPN6 protein, human; EC 3.1.3.48/PTPN7 protein, human; EC 3.1.3.48/Protein Tyrosine Phosphatase, Non-Receptor Type 6; EC 3.1.3.48/Protein Tyrosine Phosphatases; EC 3.1.3.48/Protein Tyrosine Phosphatases, Non-Receptor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcriptional activation is a key function encoded by MLL fusion partners.
Next Document:  Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mecha...